Myriad Genetics Inc. (MYGN)
8.87
-0.35 (-3.80%)
At close: Mar 28, 2025, 3:59 PM
9.45
6.54%
After-hours: Mar 28, 2025, 06:06 PM EDT
Myriad Genetics Analyst Ratings
Total Analysts
14
Consensus Rating
Hold
Price Target
20
Upside
125.48
Ratings History
| Analyst | Firm | Rating | Action | Price Target | Date |
Dave Weiner (1.18)
| Piper Sandler | Buy | Upgrades | 12 13 | Mar 12, 2025 |
Dave Weiner (1.18)
| Piper Sandler | Hold | Maintains | 14 12 | Mar 4, 2025 |
Derik De Bruin (0.28)
| B of A Securities | Sell | Maintains | 13 11 | Mar 3, 2025 |
Trade Smarter, Not Harder
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.